Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Strauss

Showing results (331-340 of 424) with videos related to

Pageof 43
Sort By:
Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.
Translational Psychiatry|September 19, 2019
The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illnessTeresa Vargas, Anthony O Ahmed, Gregory P Strauss, et al.
Gene Expression|April 23, 2020
Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in HepatocarcinogenesisRobyn P Strauss, Katherine M Audsley, Adam M Passman, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|June 24, 2021
Academic Achievement Among Children With Nonsyndromic Orofacial Clefts : A Population-Based StudyStephanie E Watkins, Robert E Meyer, Arthur S Aylsworth, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|December 15, 2006
How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak outSusan M Kegeles, Mallory O Johnson, Ronald P Strauss, et al.
Archives of General Psychiatry|February 8, 2012
Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidenceJames M Gold, James A Waltz, Tatyana M Matveeva, et al.
Schizophrenia Bulletin|February 25, 2022
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Journal of Clinical Psychopharmacology|March 30, 2021
Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Gregory P Strauss, et al.
Orthodontics & Craniofacial Research|June 8, 2007
Stigma experiences in youth with facial differences: a multi-site study of adolescents and their mothersRonald P Strauss, Barry L Ramsey, Todd C Edwards, et al.
Schizophrenia Bulletin|December 16, 2021
Machine Learning Identifies Digital Phenotyping Measures Most Relevant to Negative Symptoms in Psychotic Disorders: Implications for Clinical TrialsSayli M Narkhede, Lauren Luther, Ian M Raugh, et al.
Pageof 43

Showing results (331-340 of 424) with videos related to

Sort By:
Pageof 43
Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.
Translational Psychiatry|September 19, 2019
The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illnessTeresa Vargas, Anthony O Ahmed, Gregory P Strauss, et al.
Gene Expression|April 23, 2020
Loss of ARF/INK4A Promotes Liver Progenitor Cell Transformation Toward Tumorigenicity Supporting Their Role in HepatocarcinogenesisRobyn P Strauss, Katherine M Audsley, Adam M Passman, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|June 24, 2021
Academic Achievement Among Children With Nonsyndromic Orofacial Clefts : A Population-Based StudyStephanie E Watkins, Robert E Meyer, Arthur S Aylsworth, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|December 15, 2006
How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak outSusan M Kegeles, Mallory O Johnson, Ronald P Strauss, et al.
Archives of General Psychiatry|February 8, 2012
Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidenceJames M Gold, James A Waltz, Tatyana M Matveeva, et al.
Schizophrenia Bulletin|February 25, 2022
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Journal of Clinical Psychopharmacology|March 30, 2021
Combined Oxytocin and Cognitive Behavioral Social Skills Training for Social Function in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Gregory P Strauss, et al.
Orthodontics & Craniofacial Research|June 8, 2007
Stigma experiences in youth with facial differences: a multi-site study of adolescents and their mothersRonald P Strauss, Barry L Ramsey, Todd C Edwards, et al.
Schizophrenia Bulletin|December 16, 2021
Machine Learning Identifies Digital Phenotyping Measures Most Relevant to Negative Symptoms in Psychotic Disorders: Implications for Clinical TrialsSayli M Narkhede, Lauren Luther, Ian M Raugh, et al.
Pageof 43